Bioincubate

High speed incubator

for Life Science Discoveries

Dedicated PC2 Lab and Cleanrooms 

Speed to Market

Industry Collaboration

IP Management

Impact Investors

Gallium Medical Research Group

Gallium Maltolate is a novel colorless soluble compound, consisting of the metal gallium, commonly used in medical imaging, and the natural food additive, maltol. With more than two decades of cumulative medical research and studies, favorable evidence of effectiveness in treatment of various conditions and health benefits are being observed, including reduction of inflammation, boosting immunity, and even killing cancer cells. It has also been shown, in vitro, to inhibit SARS-CoV-2, and because of its anti-inflammatory properties, it may be a promising treatment for COVID-19 and possible future variants.

Why Bioincubate?

Validation

Within our own certified PC2Lab, we can verify novel discoveries making sure that is replicable and consistent with other scientific publications. 

Collaboration

Being a private company, we are seen as an independent facilitator so as to maximise collaboration between competing institutions.

Commercialisation

With strategic industry partners and having our own Cleanrooms for GMP, we minimise risk while accelerating time to market. 

Local Universities

With a record $8 billion investment  by the NSW Goverment in healthcare infrastructure, Bioincubate is strategically located centrally between the Sydney biotechnology precincts.

University of New South Wales
University of Sydney
University of Technology Sydney
Macquarie University
University of Newcastle
University of Wollongong

Fill out the form and we will endervour to get back to you for discussion.

Full Name*
Phone
Field of Research*
University / Institution
Please fill all the required fields!
Please accept terms and conditions to proceed

 © Copyright Bioincubate 2022

Please wait